Other Species / Isoforms
  ARHGEF5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S11-p
EEAQRGAsPPISAIE
Upstream
0 11
Treatment
  • metastatic potential
ARHGEF5 (human) EEAQRGAsPPISAIE S11-p
ARHGEF5 (mouse) EEPEYGVSTEVPDIE S11
ARHGEF5 (rat) EEPEHGACTPVPDIE C11
S184-p
SGQTRYYsPCEEHPA
0 6
ARHGEF5 (human) SGQTRYYsPCEEHPA S184-p
ARHGEF5 (mouse) SIPRGSWPPCKTHPG P180
ARHGEF5 (rat) TSTPGFWPPSKIHPG P179
S199-p
ETNQNEGsESGTIRQ
0 1
ARHGEF5 (human) ETNQNEGsESGTIRQ S199-p
ARHGEF5 (mouse) ETEQTQGSGSELLRQ S195
ARHGEF5 (rat) ETDQTEGSGMELLRQ S194
S340-p
PEENRADsQDEKSQT
0 4
ARHGEF5 (human) PEENRADsQDEKSQT S340-p
ARHGEF5 (mouse) VEERRVATQYTENQR T338
ARHGEF5 (rat) VEERRVGTQCAENQM T337
S445-p
ESRAEELsPAALsPs
Upstream
0 14
Treatment
  • ischemia
  • nocodazole
  • selumetinib
  • vemurafenib
view more >
ARHGEF5 (human) ESRAEELsPAALsPs S445-p
ARHGEF5 (mouse) EPVCEELSPQAPALE S446
ARHGEF5 (rat) EPVPEELTTQAPTPA T445
S450-p
ELsPAALsPsLEPIR
Upstream
0 17
Treatment
  • BI_4834
  • ischemia
  • nocodazole
  • selumetinib
  • vemurafenib
view more >
ARHGEF5 (human) ELsPAALsPsLEPIR S450-p
ARHGEF5 (mouse) gap -
ARHGEF5 (rat) ELTTQAPTPAPEPTE T450
S452-p
sPAALsPsLEPIRCS
0 1
ARHGEF5 (human) sPAALsPsLEPIRCS S452-p
ARHGEF5 (mouse) ELSPQAPALEPTEWS A451
ARHGEF5 (rat) TTQAPTPAPEPTEWS A452
S468-p
QPISLLGsFLTEEsP
0 1
ARHGEF5 (human) QPISLLGsFLTEEsP S468-p
ARHGEF5 (mouse) QPISPPASFAPEESL S467
ARHGEF5 (rat) QHISPPASFATEEAL S468
S474-p
GsFLTEEsPDKEIDQ
0 3
ARHGEF5 (human) GsFLTEEsPDKEIDQ S474-p
ARHGEF5 (mouse) ASFAPEESLDNRTHN S473
ARHGEF5 (rat) ASFATEEALDNRTHD A474
T494-p
ESRLRKGtVSSQGTE
0 1
ARHGEF5 (human) ESRLRKGtVSSQGTE T494-p
ARHGEF5 (mouse) EFRLRKGIEVVSAST I492
ARHGEF5 (rat) EFKLRKGTISNQGTE T493
T514-p
ASVTPPRtPDsAPPs
0 1
ARHGEF5 (human) ASVTPPRtPDsAPPs T514-p
ARHGEF5 (mouse) TSVAPSGTRDSPPFS T506
ARHGEF5 (rat) ISVAPSGTPDLPPFT T513
S517-p
TPPRtPDsAPPsPAE
0 1
ARHGEF5 (human) TPPRtPDsAPPsPAE S517-p
ARHGEF5 (mouse) APSGTRDSPPFSPPN S509
ARHGEF5 (rat) APSGTPDLPPFTPPN L516
S521-p
tPDsAPPsPAEAYPI
0 1
ARHGEF5 (human) tPDsAPPsPAEAYPI S521-p
ARHGEF5 (mouse) TRDSPPFSPPNVFSS S513
ARHGEF5 (rat) TPDLPPFTPPNVFPT T520
Y579-p
EMCPAALyGFPSTGT
0 1
ARHGEF5 (human) EMCPAALyGFPSTGT Y579-p
ARHGEF5 (mouse) LPAKSSRYPCATSDT Y565
ARHGEF5 (rat) LPAKSTRDPCATSDT D573
S606-p
VQHLRSDsFPGSHRT
Upstream
0 11
Treatment
  • ischemia
ARHGEF5 (human) VQHLRSDsFPGSHRT S606-p
ARHGEF5 (mouse) TQHLRSNsFPGSHRT S593-p
ARHGEF5 (rat) TQHLRSNSFPGSHRT S601
Y641-p
RPPKPAIyssVtPRR
Upstream
0 34
Treatment
  • Su11274
ARHGEF5 (human) RPPKPAIyssVtPRR Y641-p
ARHGEF5 (mouse) RPPKPAIYGSLTPRR Y628
ARHGEF5 (rat) RPPKTAIYGSLIPRR Y636
S642-p
PPKPAIyssVtPRRD
0 3
ARHGEF5 (human) PPKPAIyssVtPRRD S642-p
ARHGEF5 (mouse) PPKPAIYGSLTPRRN G629
ARHGEF5 (rat) PPKTAIYGSLIPRRN G637
S643-p
PKPAIyssVtPRRDR
0 3
ARHGEF5 (human) PKPAIyssVtPRRDR S643-p
ARHGEF5 (mouse) PKPAIYGSLTPRRNR S630
ARHGEF5 (rat) PKTAIYGSLIPRRNR S638
T645-p
PAIyssVtPRRDRRs
0 7
ARHGEF5 (human) PAIyssVtPRRDRRs T645-p
ARHGEF5 (mouse) PAIYGSLTPRRNRRS T632
ARHGEF5 (rat) TAIYGSLIPRRNRRS I640
S652-p
tPRRDRRsGRDystV
0 5
ARHGEF5 (human) tPRRDRRsGRDystV S652-p
ARHGEF5 (mouse) TPRRNRRSRDGIVFS S639
ARHGEF5 (rat) IPRRNRRSRDGVVFS S647
Y656-p
DRRsGRDystVsAsP
Upstream
0 96
Treatment
  • EGF
  • gefitinib
  • Su11274
view more >
ARHGEF5 (human) DRRsGRDystVsAsP Y656-p
ARHGEF5 (mouse) RNRRSRDGIVFSDSS G642
ARHGEF5 (rat) RNRRSRDGVVFSESS G650
S657-p
RRsGRDystVsAsPT
0 19
ARHGEF5 (human) RRsGRDystVsAsPT S657-p
ARHGEF5 (mouse) NRRSRDGIVFSDSST I643
ARHGEF5 (rat) NRRSRDGVVFSESSA V651
T658-p
RsGRDystVsAsPTA
0 5
ARHGEF5 (human) RsGRDystVsAsPTA T658-p
ARHGEF5 (mouse) RRSRDGIVFSDSSTA V644
ARHGEF5 (rat) RRSRDGVVFSESSAA V652
S660-p
GRDystVsAsPTALS
0 1
ARHGEF5 (human) GRDystVsAsPTALS S660-p
ARHGEF5 (mouse) SRDGIVFSDSSTALF S646
ARHGEF5 (rat) SRDGVVFSESSAALF S654
S662-p
DystVsAsPTALSTL
0 8
ARHGEF5 (human) DystVsAsPTALSTL S662-p
ARHGEF5 (mouse) DGIVFSDSSTALFAL S648
ARHGEF5 (rat) DGVVFSESSAALFAL S656
T735-p
PPPQRRDtHPSVVET
0 6
ARHGEF5 (human) PPPQRRDtHPSVVET T735-p
ARHGEF5 (mouse) IPPEKRHsYSHIVER S720-p
ARHGEF5 (rat) PPPEKRHSYSHIVER S727
S757-p
VPTLKQHsHPPPLAL
0 5
ARHGEF5 (human) VPTLKQHsHPPPLAL S757-p
ARHGEF5 (mouse) ASTLKRHsHPPPLTL S742-p
ARHGEF5 (rat) AATLKRHSHPPPLTL S749
P775
LHAPHKGPLPQASDP
0 1
ARHGEF5 (human) LHAPHKGPLPQASDP P775
ARHGEF5 (mouse) LHRSSKGsFSLVPDS S760-p
ARHGEF5 (rat) LHRSPKGSFSLVPDS S767
R789-m1
PAVARQHrPLPsTPD
0 1
ARHGEF5 (human) PAVARQHrPLPsTPD R789-m1
ARHGEF5 (mouse) STVARQHRPLPStPE R774
ARHGEF5 (rat) SVVARQHRPLPSTPE R781
S793-p
RQHrPLPsTPDSSHH
0 1
ARHGEF5 (human) RQHrPLPsTPDSSHH S793-p
ARHGEF5 (mouse) RQHRPLPStPEsPNH S778
ARHGEF5 (rat) RQHRPLPSTPEGSHH S785
T794
QHrPLPsTPDSSHHA
0 1
ARHGEF5 (human) QHrPLPsTPDSSHHA T794
ARHGEF5 (mouse) QHRPLPStPEsPNHT T779-p
ARHGEF5 (rat) QHRPLPSTPEGSHHT T786
S797
PLPsTPDSSHHAQAt
0 5
ARHGEF5 (human) PLPsTPDSSHHAQAt S797
ARHGEF5 (mouse) PLPStPEsPNHTQTS S782-p
ARHGEF5 (rat) PLPSTPEGSHHTQTS G789
T804-p
SSHHAQAtPRWRYNK
0 1
ARHGEF5 (human) SSHHAQAtPRWRYNK T804-p
ARHGEF5 (mouse) sPNHTQTSIPSRLRY S789
ARHGEF5 (rat) GSHHTQTSIPSRLRY S796
T816-p
YNKPLPPtPDLPQPH
0 1
ARHGEF5 (human) YNKPLPPtPDLPQPH T816-p
ARHGEF5 (mouse) YNKPLPPTPDMPEFY T803
ARHGEF5 (rat) YNKPLPPTPDMPEPC T810
S828-p
QPHLPPIsAPGSSRI
0 1
ARHGEF5 (human) QPHLPPIsAPGSSRI S828-p
ARHGEF5 (mouse) EFYHPSISSSYISRM S815
ARHGEF5 (rat) EPCHSSISSSNISRI S822
Y836-p
APGSSRIyRPLPPLP
0 38
ARHGEF5 (human) APGSSRIyRPLPPLP Y836-p
ARHGEF5 (mouse) SSYISRMYRPLPPVP Y823
ARHGEF5 (rat) SSNISRIYRPLPPVP Y830
T849-p
LPIIDPPtEPPPLPP
0 1
ARHGEF5 (human) LPIIDPPtEPPPLPP T849-p
ARHGEF5 (mouse) VPIIDPSSEPPPLPP S836
ARHGEF5 (rat) VPITDPSSEPPPLPP S843
S864
KSRGRSRSTrGGHMN
0 5
ARHGEF5 (human) KSRGRSRSTrGGHMN S864
ARHGEF5 (mouse) KSRGRSKsIQGGVIH S851-p
ARHGEF5 (rat) KSRERSRSVQVGVMH S858
R866-m2
RGRSRSTrGGHMNSG
0 2
ARHGEF5 (human) RGRSRSTrGGHMNSG R866-m2
ARHGEF5 (mouse) RGRSKsIQGGVIHSG Q853
ARHGEF5 (rat) RERSRSVQVGVMHSM Q860
T896-p
LPASAGRtsWPPATA
0 1
ARHGEF5 (human) LPASAGRtsWPPATA T896-p
ARHGEF5 (mouse) STLSVGRTSWPPATG T882
ARHGEF5 (rat) STLSVGRTSWPPATG T889
S897-p
PASAGRtsWPPATAR
0 2
ARHGEF5 (human) PASAGRtsWPPATAR S897-p
ARHGEF5 (mouse) TLSVGRTSWPPATGR S883
ARHGEF5 (rat) TLSVGRTSWPPATGR S890
S908-p
ATARSTEsFTSTsRS
Upstream
0 2
Treatment
  • ischemia
ARHGEF5 (human) ATARSTEsFTSTsRS S908-p
ARHGEF5 (mouse) ATGRSTESLPLTSRC S894
ARHGEF5 (rat) ATGRSTESLPPTSRC S901
S913-p
TEsFTSTsRSKSEVS
0 1
ARHGEF5 (human) TEsFTSTsRSKSEVS S913-p
ARHGEF5 (mouse) TESLPLTSRCNNEVS S899
ARHGEF5 (rat) TESLPPTSRCNSEVS S906
P967
PEAPAREPLRRTtPQ
0 1
ARHGEF5 (human) PEAPAREPLRRTtPQ P967
ARHGEF5 (mouse) SEPPVRGsFRRSAPQ S953-p
ARHGEF5 (rat) SAPPVRGSFRRPALQ S960
T972-p
REPLRRTtPQQGAsG
0 2
ARHGEF5 (human) REPLRRTtPQQGAsG T972-p
ARHGEF5 (mouse) RGsFRRSAPQEEFNN A958
ARHGEF5 (rat) RGSFRRPALQEEFNN A965
S978-p
TtPQQGAsGPGRsPV
0 2
ARHGEF5 (human) TtPQQGAsGPGRsPV S978-p
ARHGEF5 (mouse) SAPQEEFNNTRRSAL N964
ARHGEF5 (rat) PALQEEFNNTRRSAL N971
S983-p
GAsGPGRsPVGQARQ
0 8
ARHGEF5 (human) GAsGPGRsPVGQARQ S983-p
ARHGEF5 (mouse) EFNNTRRSALGSRKN S969
ARHGEF5 (rat) EFNNTRRSALGSRKK S976
P991
PVGQARQPEKPSHLH
0 1
ARHGEF5 (human) PVGQARQPEKPSHLH P991
ARHGEF5 (mouse) ALGSRKNsEKPLHHQ S977-p
ARHGEF5 (rat) ALGSRKKSEKPIHYQ S984
S1011-p
SWPHRRDsGRPPGDS
0 7
ARHGEF5 (human) SWPHRRDsGRPPGDS S1011-p
ARHGEF5 (mouse) SWPHRRDPARTSESS P997
ARHGEF5 (rat) SWPHRRDTARTSESS T1004
S1036-p
ANKHKGWsRQGLRRP
Upstream
0 1
Treatment
  • ischemia
ARHGEF5 (human) ANKHKGWsRQGLRRP S1036-p
ARHGEF5 (mouse) PNKQKGWNRQGLRRP N1021
ARHGEF5 (rat) PNKQKGWNRQGLRRP N1028
S1044-p
RQGLRRPsILPEGSS
0 28
ARHGEF5 (human) RQGLRRPsILPEGSS S1044-p
ARHGEF5 (mouse) RQGLRRPsILPESSS S1029-p
ARHGEF5 (rat) RQGLRRPsILPESSS S1036-p
K1060-ub
SRGPAVEkHPGPSDT
0 2
ARHGEF5 (human) SRGPAVEkHPGPSDT K1060-ub
ARHGEF5 (mouse) LRNPAAGRLPGSSDS R1045
ARHGEF5 (rat) LRNPAAGRLPGSSDS R1052
S1083-p
KEVMGGFsRRCsKLI
0 1
ARHGEF5 (human) KEVMGGFsRRCsKLI S1083-p
ARHGEF5 (mouse) KEGMGGFSRRCSKLI S1068
ARHGEF5 (rat) KEGMGGFSRRCsKLI S1075
S1087-p
GGFsRRCsKLINsSQ
0 6
ARHGEF5 (human) GGFsRRCsKLINsSQ S1087-p
ARHGEF5 (mouse) GGFSRRCSKLISSQL S1072
ARHGEF5 (rat) GGFSRRCsKLINSSQ S1079-p
S1092-p
RCsKLINsSQLLyQE
0 3
ARHGEF5 (human) RCsKLINsSQLLyQE S1092-p
ARHGEF5 (mouse) RRCSKLISSQLLYQE S1076
ARHGEF5 (rat) RCsKLINSSQLLYQE S1084
Y1097-p
INsSQLLyQEySDVV
Upstream
0 47
Treatment
  • EGF
  • erlotinib
ARHGEF5 (human) INsSQLLyQEySDVV Y1097-p
ARHGEF5 (mouse) LISSQLLYQEYSDVV Y1081
ARHGEF5 (rat) INSSQLLYQEYSDVV Y1089
Y1100-p
SQLLyQEySDVVLNk
Upstream
0 14
Treatment
  • EGF
ARHGEF5 (human) SQLLyQEySDVVLNk Y1100-p
ARHGEF5 (mouse) SQLLYQEYSDVVLNK Y1084
ARHGEF5 (rat) SQLLYQEYSDVVLNK Y1092
K1107-ub
ySDVVLNkEIQSQQR
0 2
ARHGEF5 (human) ySDVVLNkEIQSQQR K1107-ub
ARHGEF5 (mouse) YSDVVLNKEIQSQQR K1091
ARHGEF5 (rat) YSDVVLNKEIQSQQR K1099
S1117-p
QSQQRLEsLsEtPGP
0 4
ARHGEF5 (human) QSQQRLEsLsEtPGP S1117-p
ARHGEF5 (mouse) QSQQRLDsLAEPHGL S1101-p
ARHGEF5 (rat) QSQQRLDSLAEPPGI S1109
S1119-p
QQRLEsLsEtPGPss
0 1
ARHGEF5 (human) QQRLEsLsEtPGPss S1119-p
ARHGEF5 (mouse) QQRLDsLAEPHGLss A1103
ARHGEF5 (rat) QQRLDSLAEPPGISS A1111
T1121-p
RLEsLsEtPGPssPR
0 2
ARHGEF5 (human) RLEsLsEtPGPssPR T1121-p
ARHGEF5 (mouse) RLDsLAEPHGLssPR P1105
ARHGEF5 (rat) RLDSLAEPPGISSPR P1113
S1125-p
LsEtPGPssPRQPRK
Upstream
0 9
Treatment
  • nocodazole
ARHGEF5 (human) LsEtPGPssPRQPRK S1125-p
ARHGEF5 (mouse) LAEPHGLssPRHRRK S1109-p
ARHGEF5 (rat) LAEPPGISSPRYRRK S1117
S1126-p
sEtPGPssPRQPRKA
Upstream
0 23
Treatment
  • EGF
  • nocodazole
ARHGEF5 (human) sEtPGPssPRQPRKA S1126-p
ARHGEF5 (mouse) AEPHGLssPRHRRKA S1110-p
ARHGEF5 (rat) AEPPGISSPRYRRKA S1118
S1136-p
QPRKALVsSESyLQR
0 4
ARHGEF5 (human) QPRKALVsSESyLQR S1136-p
ARHGEF5 (mouse) HRRKALVsSDsYLQR S1120-p
ARHGEF5 (rat) YRRKALVSSDSYLQR S1128
S1139
KALVsSESyLQRLsM
0 1
ARHGEF5 (human) KALVsSESyLQRLsM S1139
ARHGEF5 (mouse) KALVsSDsYLQRLSM S1123-p
ARHGEF5 (rat) KALVSSDSYLQRLSM S1131
Y1140-p
ALVsSESyLQRLsMA
0 1
ARHGEF5 (human) ALVsSESyLQRLsMA Y1140-p
ARHGEF5 (mouse) ALVsSDsYLQRLSMA Y1124
ARHGEF5 (rat) ALVSSDSYLQRLSMA Y1132
S1145-p
ESyLQRLsMASSGSL
0 1
ARHGEF5 (human) ESyLQRLsMASSGSL S1145-p
ARHGEF5 (mouse) DsYLQRLSMASSGSL S1129
ARHGEF5 (rat) DSYLQRLSMASSGSL S1137
T1163-p
IPVVRNStVLLSMTH
0 1
ARHGEF5 (human) IPVVRNStVLLSMTH T1163-p
ARHGEF5 (mouse) IPVVRNSTVLLSMTH T1147
ARHGEF5 (rat) IPVVRNSTVLLSMTH T1155
S1188-p
ELIVSEAsyLRSLNI
0 1
ARHGEF5 (human) ELIVSEAsyLRSLNI S1188-p
ARHGEF5 (mouse) ELIVSEASYLRSLNI S1172
ARHGEF5 (rat) ELIVSEASYLRSLNI S1180
Y1189-p
LIVSEAsyLRSLNIA
0 1
ARHGEF5 (human) LIVSEAsyLRSLNIA Y1189-p
ARHGEF5 (mouse) LIVSEASYLRSLNIA Y1173
ARHGEF5 (rat) LIVSEASYLRSLNIA Y1181
Y1273-p
PYVTNQTyQERtFQs
0 3
ARHGEF5 (human) PYVTNQTyQERtFQs Y1273-p
ARHGEF5 (mouse) PYVTNQTYQERTFQS Y1257
ARHGEF5 (rat) PYVTNQTYQERTFQS Y1265
T1277-p
NQTyQERtFQsLMNs
0 1
ARHGEF5 (human) NQTyQERtFQsLMNs T1277-p
ARHGEF5 (mouse) NQTYQERTFQSLMNS T1261
ARHGEF5 (rat) NQTYQERTFQSLMNS T1269
S1280-p
yQERtFQsLMNsNsN
0 1
ARHGEF5 (human) yQERtFQsLMNsNsN S1280-p
ARHGEF5 (mouse) YQERTFQSLMNSNSS S1264
ARHGEF5 (rat) YQERTFQSLMNSNSS S1272
S1284-p
tFQsLMNsNsNFREV
0 1
ARHGEF5 (human) tFQsLMNsNsNFREV S1284-p
ARHGEF5 (mouse) TFQSLMNSNSSFREV S1268
ARHGEF5 (rat) TFQSLMNSNSSFREV S1276
S1286-p
QsLMNsNsNFREVLE
0 1
ARHGEF5 (human) QsLMNsNsNFREVLE S1286-p
ARHGEF5 (mouse) QSLMNSNSSFREVLE S1270
ARHGEF5 (rat) QSLMNSNSSFREVLE S1278
K1343-ub
SEEAEATkAHHALEQ
0 3
ARHGEF5 (human) SEEAEATkAHHALEQ K1343-ub
ARHGEF5 (mouse) SEEAEATKAHHALEK K1327
ARHGEF5 (rat) SEEAEATKAHHALEK K1335
Y1370-p
RRTEELIyLSQKIEF
0 59
ARHGEF5 (human) RRTEELIyLSQKIEF Y1370-p
ARHGEF5 (mouse) RRTEELIYLSQKIEF Y1354
ARHGEF5 (rat) RRTEELIYLSQKIEF Y1362
S1403-p
ELTALEFsAsPGLRR
0 1
ARHGEF5 (human) ELTALEFsAsPGLRR S1403-p
ARHGEF5 (mouse) ELTALEFSVSPGLRR S1387
ARHGEF5 (rat) ELTALEFSVSPGLKR S1395
S1405-p
TALEFsAsPGLRRKL
0 7
ARHGEF5 (human) TALEFsAsPGLRRKL S1405-p
ARHGEF5 (mouse) TALEFSVSPGLRRKL S1389
ARHGEF5 (rat) TALEFSVSPGLKRKL S1397
T1473-p
RLFLRQNtQGAQAEF
0 1
ARHGEF5 (human) RLFLRQNtQGAQAEF T1473-p
ARHGEF5 (mouse) RLFLLHNAQGTQVEF A1457
ARHGEF5 (rat) RLFLLHNAQGTQAEF A1465